scholarly article | Q13442814 |
P2093 | author name string | K. Yamamoto | |
T. Watanabe | |||
S. Okamoto | |||
H. Shimizu | |||
K. Mitomo | |||
P2860 | cites work | DNA sequencing with chain-terminating inhibitors | Q22066207 |
Structure and expression of cDNA and genes for human interferon-beta-2, a distinct species inducible by growth-stimulatory cytokines | Q24295244 | ||
Multiple nuclear factors interact with the immunoglobulin enhancer sequences | Q24296245 | ||
Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6 | Q24297617 | ||
Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin | Q24299103 | ||
Cloning and expression in Escherichia coli of the gene for human tumour necrosis factor | Q24300078 | ||
Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells | Q24322083 | ||
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease | Q26778460 | ||
Bacterial lipopolysaccharide (endotoxin) enhances expression and secretion of beta 2 interferon by human fibroblasts | Q27485094 | ||
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells | Q27860607 | ||
Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei | Q27860728 | ||
Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor | Q28288345 | ||
Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements | Q28288355 | ||
Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor | Q28615489 | ||
Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B | Q29618096 | ||
An inducible transcription factor activates expression of human immunodeficiency virus in T cells | Q29618434 | ||
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism | Q29619866 | ||
Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter | Q33562993 | ||
Identification and purification of a human immunoglobulin-enhancer-binding protein (NF-kappa B) that activates transcription from a human immunodeficiency virus type 1 promoter in vitro | Q33584734 | ||
Activation of the human "beta 2-interferon/hepatocyte-stimulating factor/interleukin 6" promoter by cytokines, viruses, and second messenger agonists | Q33647124 | ||
Enhancement of cAMP levels and of protein kinase activity by tumor necrosis factor and interleukin 1 in human fibroblasts: role in the induction of interleukin 6 | Q33647899 | ||
Multiple biological activities are expressed by a mouse interleukin 6 cDNA clone isolated from bone marrow stromal cells | Q33650453 | ||
Cyclic AMP induction of early adenovirus promoters involves sequences required for E1A trans-activation | Q33651246 | ||
NF-kappa B protein purification from bovine spleen: nucleotide stimulation and binding site specificity | Q33676218 | ||
Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes | Q33847436 | ||
B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF). | Q33930223 | ||
A cellular protein, activating transcription factor, activates transcription of multiple E1A-inducible adenovirus early promoters | Q34370164 | ||
A common positive trans-acting factor binds to enhancer sequences in the promoters of mouse H-2 and beta 2-microglobulin genes | Q34616824 | ||
Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor | Q36352519 | ||
Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor | Q36423810 | ||
Anti-beta-interferon antibodies inhibit the increased expression of HLA-B7 mRNA in tumor necrosis factor-treated human fibroblasts: structural studies of the beta 2 interferon involved | Q36463524 | ||
Structural analysis of the sequence coding for an inducible 26-kDa protein in human fibroblasts | Q36479212 | ||
Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein | Q36767392 | ||
A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1 | Q36833475 | ||
Binding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility gene | Q36833546 | ||
c-fos sequence necessary for basal expression and induction by epidermal growth factor, 12-O-tetradecanoyl phorbol-13-acetate and the calcium ionophore | Q36922259 | ||
Cachectin and tumour necrosis factor as two sides of the same biological coin | Q39501245 | ||
Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities | Q39507424 | ||
Involvement of a cis-element that binds an H2TF-1/NF kappa B like factor(s) in the virus-induced interferon-beta gene expression | Q40449231 | ||
High level transient expression of a chloramphenicol acetyl transferase gene by DEAE-dextran mediated DNA transfection coupled with a dimethyl sulfoxide or glycerol shock treatment. | Q40461112 | ||
Sequence requirement for specific interaction of an enhancer binding protein (EBP1) with DNA. | Q40520724 | ||
Structure and expression of human B cell stimulatory factor-2 (BSF-2/IL-6) gene | Q41349604 | ||
Involvement of a common transcription factor in the regulated expression of IL-2 and IL-2 receptor genes | Q41967810 | ||
The human beta-interferon gene enhancer is under negative control | Q42524799 | ||
Structural diversity of murine serum amyloid A genes. Evolutionary implications. | Q43736788 | ||
Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha | Q43819767 | ||
The involvement of NF-kappa B in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction | Q44684470 | ||
Cooperativity of glucocorticoid response elements located far upstream of the tyrosine aminotransferase gene | Q48346657 | ||
Identification of two distinct regulatory regions adjacent to the human β-interferon gene | Q48395961 | ||
HTLV-1 transactivator induces interleukin-2 receptor expression through an NF-kappa B-like factor. | Q55242466 | ||
Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors | Q58485006 | ||
A nuclear factor that binds to a conserved sequence motif in transcriptional control elements of immunoglobulin genes | Q59066385 | ||
Activation of HIV gene expression during monocyte differentiation by induction of NF-kB | Q59073190 | ||
Transcriptional regulation of the interferon-beta 2/B cell differentiation factor BSF-2/hepatocyte-stimulating factor gene in human fibroblasts by other cytokines | Q68125488 | ||
Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells | Q68181266 | ||
Human beta 2 interferon and B-cell differentiation factor BSF-2 are identical | Q68813251 | ||
The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV | Q69827093 | ||
Multiple actions of interleukin 6 within a cytokine network | Q70268577 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | interleukins | Q194908 |
NF-κB | Q411114 | ||
inflammation | Q101991 | ||
P304 | page(s) | 561–568 | |
P577 | publication date | 1990-02-01 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines | |
P478 | volume | 10 |
Q54674107 | A case-control study in IL6 and TGFB1 gene polymorphisms and recurrent spontaneous abortion in southern Brazilian patients. |
Q40757748 | A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: the MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production |
Q40678565 | A lymphoid cell-specific nuclear factor containing c-Rel-like proteins preferentially interacts with interleukin-6 kappa B-related motifs whose activities are repressed in lymphoid cells |
Q52692695 | A mouse model study of toxicity and biodistribution of a replication defective adenovirus serotype 5 virus with its genome engineered to contain a decoy hyper binding site to sequester and suppress oncogenic HMGA1 as a new cancer treatment therapy. |
Q50286961 | Activated CEBPB and NFKB complex bind IL6 promoter |
Q35100850 | Activation of the interleukin 6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by nuclear factors NF-IL6 and NF-kappa B. |
Q29547882 | Activators and target genes of Rel/NF-kappaB transcription factors |
Q41028807 | Air pollution particles induce IL-6 gene expression in human airway epithelial cells via NF-kappaB activation |
Q36925011 | An 11-base-pair DNA sequence motif apparently unique to the human interleukin 4 gene confers responsiveness to T-cell activation signals |
Q38317944 | An NF-kappa B-like element plays an essential role in interleukin-1-mediated costimulation of the mouse interleukin-2 promoter |
Q84996896 | Anti-ribosomal P protein antibody induces Th1 responses by enhancing the production of IL-12 in activated monocytes |
Q64092041 | Antineuroinflammatory and Neuroprotective Effects of Gyejibokryeong-Hwan in Lipopolysaccharide-Stimulated BV2 Microglia |
Q40406392 | Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells |
Q34044038 | Atopy and asthma genes--where do we stand? |
Q38363498 | Binding of C/EBP and RBP (CBF1) to overlapping sites regulates interleukin-6 gene expression |
Q36364736 | CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide |
Q36365289 | Ceramide induces interleukin 6 gene expression in human fibroblasts |
Q36705484 | Characterization of a new tissue-specific transcription factor binding to the simian virus 40 enhancer TC-II (NF-kappa B) element |
Q29618284 | Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity |
Q40021606 | Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors |
Q52717455 | Chronic calcitriol supplementation improves the inflammatory profiles of circulating monocytes and the associated intestinal/adipose tissue alteration in a diet-induced steatohepatitis rat model. |
Q48039355 | Cloning and characterization of the promoter for the human complement factor I (C3b/C4b inactivator) gene |
Q24316435 | Cloning of a differentially expressed I kappa B-related protein |
Q72611643 | Co-stimulation of T cells via CD28 inhibits human IgE production; reversal by pertussis toxin |
Q41036494 | Comparative cytokine gene expression: regulation and release by human mast cells |
Q41733125 | Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene |
Q42049241 | Constitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-kappaB and CBF1. |
Q57240746 | Coordinate and Differential Regulation of GM-CSF and IL-3 Synthesis in Murine T Lymphocytes |
Q40436152 | Corticosteroid sparing agents in asthma |
Q42152964 | Cyclic AMP-independent activation of transcription factor NF-kappa B in HL60 cells by tumor necrosis factors alpha and beta |
Q54765330 | Cytokine gene expression--part of host defence in pulpitis. |
Q68236788 | Cytokine regulation of interleukin-6 gene expression in astrocytes involves activation of an NF-κ B-like nuclear protein |
Q40873605 | Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. |
Q40804439 | Differential involvement of p38 mitogen-activated protein kinase and phosphatidyl inositol 3-kinase in the IL-1-mediated NF-kappa B and AP-1 activation |
Q40962924 | Differential regulation of IL-6 promoter activity in a human ovarian-tumor cell line transfected with various p53 mutants: involvement of AP-1. |
Q37726379 | Differentiation by NK cells is a prerequisite for effective targeting of cancer stem cells/poorly differentiated tumors by chemopreventive and chemotherapeutic drugs. |
Q34532234 | Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages |
Q46115467 | Effects of interleukin-10 on titanium particle-induced macrophage transcription factor activation and cytokine expression in vitro |
Q30819310 | Effects of low-level laser therapy (LLLT) on the nuclear factor (NF)-kappaB signaling pathway in traumatized muscle. |
Q48175000 | Effects of systemic immunogenic insults and circulating proinflammatory cytokines on the transcription of the inhibitory factor kappaB alpha within specific cellular populations of the rat brain |
Q37747013 | Expression and function of interleukin-6 in epithelial cells |
Q30751733 | Fine mapping and single nucleotide polymorphism association results of candidate genes for asthma and related phenotypes. |
Q40723978 | Flavonoids exert diverse inhibitory effects on the activation of NF-kappaB. |
Q73195896 | Functional disparity of distinct CD28 response elements toward mitogenic responses |
Q42490328 | Functional role of the cis-acting elements in human monocyte chemotactic protein-1 gene in the regulation of its expression by phorbol ester in human glioblastoma cells |
Q41711827 | Gene expression, biological effects and clinical aspects of lymphokines |
Q33708904 | Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation |
Q38331021 | Glycosylation of interleukin-6 purified from normal human blood mononuclear cells. |
Q34721325 | G‐protein coupled receptor kinase 5 mediates lipopolysaccharide‐induced NFκB activation in primary macrophages and modulates inflammation in vivo in mice |
Q41010028 | Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release |
Q38327000 | Hepatitis B virus transactivator MHBst: activation of NF-kappa B, selective inhibition by antioxidants and integral membrane localization |
Q40394411 | Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanisms |
Q45067683 | Histamine induces Toll-like receptor 2 and 4 expression in endothelial cells and enhances sensitivity to Gram-positive and Gram-negative bacterial cell wall components |
Q73764580 | Human alpha-galactosidase A: high plasma activity expressed by the -30G-->A allele |
Q35857715 | Human immunodeficiency virus type 1-associated CD40 ligand transactivates B lymphocytes and promotes infection of CD4+ T cells |
Q36175606 | Hyperthermia increases interleukin-6 in mouse skeletal muscle |
Q35332588 | IL-6 and NF-IL6 in acute-phase response and viral infection |
Q36268717 | IL-6 receptor and mechanism of signal transduction |
Q40016928 | Identification of a novel p53 promoter element involved in genotoxic stress-inducible p53 gene expression |
Q42483793 | Identification of the IL-6-responsive element in an acute-phase-responsive human pancreatic secretory trypsin inhibitor-encoding gene |
Q38357382 | Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B). Implications for FK506 nephropathy |
Q34512542 | Impairment of bilirubin clearance and intestinal interleukin-6 expression in bile duct-ligated vitamin D receptor null mice |
Q37726565 | In vivo anergized CD4+ T cells express perturbed AP-1 and NF-kappa B transcription factors |
Q41026080 | Increased interleukin-6 production in mouse osteoblastic MC3T3-E1 cells expressing activating mutant of the stimulatory G protein |
Q24812987 | Inducible nitric oxide synthase links NF-kappaB to PGE2 in polyunsaturated fatty acid altered fibroblast in-vitro wound healing |
Q41101705 | Induction of interleukin 6 by ionizing radiation in a human epithelial cell line: control by corticosteroids |
Q35162371 | Inflammatory signaling in NEC: Role of NF-κB, cytokines and other inflammatory mediators |
Q40953203 | Inhibition of GM-CSF production by recombinant human interleukin-4: negative regulator of hematopoiesis |
Q35997495 | Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor |
Q38312785 | Interferon-alpha synergistically enhances induction of interleukin-6 by double stranded RNA in HeLa cells |
Q31378956 | Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-kappaB. |
Q44434230 | Interleukin (IL)-4 production by human T cells: differential regulation of IL-4 vs. IL-2 production |
Q37771134 | Interleukin 6 (IL-6) and its receptor: their role in plasma cell neoplasias |
Q38017637 | Interleukin 6 (IL-6). |
Q40933534 | Interleukin-1 receptor antagonist inhibits interleukin-8 expression in A549 respiratory epithelial cells infected in vitro with a replication-deficient recombinant adenovirus vector |
Q38338064 | Interleukin-1-mediated enhancement of mouse factor B gene expression via NF kappa B-like hepatoma nuclear factor |
Q41289518 | Interleukin-4 inhibits kappa light chain expression and NF kappa B activation but not I kappa B alpha degradation in 70Z/3 murine pre-B cells |
Q33850723 | Interleukin-6 expression and regulation in astrocytes |
Q33907983 | Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro |
Q40850225 | Interleukin-6 in biology and medicine |
Q34002739 | Involvement of protein kinase C in Rickettsia rickettsii-induced transcriptional activation of the host endothelial cell. |
Q40607094 | Iron metabolism in inflammation |
Q59154797 | Is the interleukin-6 haplotype a prognostic factor for sciatica? |
Q24534690 | Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways |
Q36230640 | Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites |
Q35320801 | Lymphokine production by B cells from normal and HIV-infected individuals |
Q41513908 | Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. |
Q36376086 | Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor |
Q40941182 | Molecular biology of cytokines |
Q36754228 | Molecular cloning and characterization of a ruminant interleukin-6 cDNA. |
Q24675633 | Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling |
Q73933734 | Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-gamma |
Q38306725 | Multiple regulatory elements in the interleukin-6 gene mediate induction by prostaglandins, cyclic AMP, and lipopolysaccharide. |
Q44237840 | Mutational analysis of the kinetics and thermodynamics of transcription factor NF-kappaB homodimerisation |
Q54221405 | N-myc downstream-regulated gene 4, up-regulated by tumor necrosis factor-α and nuclear factor kappa B, aggravates cardiac ischemia/reperfusion injury by inhibiting reperfusion injury salvage kinase pathway. |
Q36695427 | NF-AB, a liver-specific and cytokine-inducible nuclear factor that interacts with the interleukin-1 response element of the rat alpha 1-acid glycoprotein gene |
Q24336834 | NF-kappa B and C/EBP transcription factor families synergistically function in mouse serum amyloid A gene expression induced by inflammatory cytokines |
Q40884567 | NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. |
Q33930920 | NF-kappaB/rel/IkappaB: implications in gastrointestinal diseases |
Q41664014 | NF-κB activity in T cells stably expressing the Tax protein of human T cell lymphotropic virus type I |
Q39815536 | Notch1 upregulates LPS-induced macrophage activation by increasing NF-kappaB activity |
Q41180081 | Nuclear factor kappa B (NF-kappa B), nuclear factor interleukin-6 (NFIL-6 or C/EBP beta) and nuclear factor interleukin-6 beta (NFIL6-beta or C/EBP delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma |
Q40825105 | Nuclear factor kappa B, a mediator of lipopolysaccharide effects |
Q30424684 | Nuclear factor of activated T cells 5 regulates vascular smooth muscle cell phenotypic modulation |
Q36617731 | Nuclear factor-kappab (NF-kappaB): an unsuspected major culprit in the pathogenesis of endometriosis that is still at large? |
Q34297418 | Nutritional modulation of acute- and "chronic" -phase responses. |
Q36732089 | On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion |
Q24316077 | Organic dust activates NF-kappaB in lung epithelial cells |
Q73783534 | Parathyroid hormone (1-34)-mediated interleukin-6 induction |
Q28572033 | Participation of prostaglandin E2 and platelet-activating factor in thapsigargin-induced production of interleukin-6 |
Q39042054 | Periostin controls keratinocyte proliferation and differentiation by interacting with the paracrine IL-1α/IL-6 loop |
Q48987450 | Pigment epithelium-derived factor induces pro-inflammatory genes in neonatal astrocytes through activation of NF-kappa B and CREB. |
Q44031567 | Possible participation of intracellular platelet-activating factor in NF-kappaB activation in rat peritoneal macrophages. |
Q35765098 | Production of interleukin-6 by synovial fibroblasts in rheumatoid arthritis. |
Q42497408 | Promoter elements in the transcriptional activation of the human stromelysin-1 gene by the inflammatory cytokine, interleukin 1. |
Q47232399 | Proteasome and Organs Ischemia-Reperfusion Injury |
Q36739370 | Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension |
Q36569110 | Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor |
Q23922293 | Regulation and role of interleukin 6 in wounded human epithelial keratinocytes |
Q50286962 | Regulation of IL6 transcription |
Q42832547 | Regulation of NF-kappaB-dependent gene expression by the POU domain transcription factor Oct-1. |
Q41881846 | Regulation of interleukin 1 signalling through integrin binding and actin reorganization: disparate effects on NF-kappaB and stress kinase pathways. |
Q41531127 | Regulation of interleukin-6 (IL-6) expression: evidence for a tissue-specific role of protein kinase C. |
Q48826853 | Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor kappaB. |
Q40944786 | Regulation of spontaneous and TNF/IFN-induced IL-6 expression in two human ovarian-carcinoma cell lines. |
Q73782198 | Regulation of the C-X-C chemokine, mob-1, gene expression in primary rat hepatocytes |
Q40652389 | Regulatory Effect of SOCS on NF-κB Activity in Murine Monocytes/Macrophages |
Q41105715 | Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor |
Q35551066 | Rickettsia rickettsii infection of cultured human endothelial cells induces NF-kappaB activation |
Q33460419 | SOD3 reduces inflammatory cell migration by regulating adhesion molecule and cytokine expression |
Q40692803 | Salivary cystatins induce interleukin-6 expression via cell surface molecules in human gingival fibroblasts |
Q41678141 | Sensitivity to tumour necrosis factor-mediated cytolysis is unrelated to manganous superoxide dismutase messenger RNA levels among transformed mouse fibroblasts |
Q42983026 | Signal transduction pathways in mast cell granule-mediated endothelial cell activation |
Q37473453 | Signal transduction pathways involved in brain death-induced renal injury |
Q40258257 | Species differential regulation of COX2 can be described by an NFκB-dependent logic AND gate |
Q41993580 | Staurosporine, but not Ro 31-8220, induces interleukin 2 production and synergizes with interleukin 1alpha in EL4 thymoma cells |
Q43671895 | Stimulation of interleukin-6 promoter by parathyroid hormone, tumor necrosis factor alpha, and interleukin-1beta in UMR-106 osteoblastic cells is inhibited by protein kinase C antagonists |
Q41462066 | Susceptibility genes for allergy and asthma |
Q35157197 | Synthesis of IL-6 by hepatocytes is a normal response to common hepatic stimuli |
Q41623874 | TNF‐mediated IL6 gene expression and cytotoxicity are co‐inducible in TNF‐resistant L929 cells |
Q40664782 | TRAF6 and C-SRC induce synergistic AP-1 activation via PI3-kinase-AKT-JNK pathway |
Q34646701 | Targeted adenoviral vectors |
Q39390630 | Targeting interlukin-6 to relieve immunosuppression in tumor microenvironment |
Q58117312 | Tart Cherry Reduces Inflammation in Adipose Tissue of Zucker Fatty Rats and Cultured 3T3-L1 Adipocytes |
Q35604441 | The DNA methylation drift of the atherosclerotic aorta increases with lesion progression |
Q36719063 | The cytokine response element of the rat alpha 1-acid glycoprotein gene is a complex of several interacting regulatory sequences |
Q37057476 | The death domain kinase RIP1 is essential for tumor necrosis factor alpha signaling to p38 mitogen-activated protein kinase |
Q41915919 | The effect of interleukin-1 on C-reactive protein expression in Hep3B cells is exerted at the transcriptional level |
Q36564525 | The mammalian transcriptional repressor RBP (CBF1) regulates interleukin-6 gene expression |
Q33993411 | The proteasome inhibitor MG132 reduces immobilization-induced skeletal muscle atrophy in mice |
Q35899034 | The role of Kupffer cell activation and viral gene expression in early liver toxicity after infusion of recombinant adenovirus vectors. |
Q35127430 | The role of the interleukin‐6 family of cytokines in inflammatory arthritis and bone turnover |
Q41489212 | Transcriptional regulation of the gene for the second component of human complement: promoter analysis |
Q40894302 | Transcriptional regulatory effects of lymphoma-associated NFKB2/lyt10 protooncogenes |
Q38289102 | Triggering of the human interleukin-6 gene by interferon-gamma and tumor necrosis factor-alpha in monocytic cells involves cooperation between interferon regulatory factor-1, NF kappa B, and Sp1 transcription factors |
Q38504329 | Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation |
Q74411614 | Tumor necrosis factor receptor deletion reduces nuclear factor-kappaB activation, cellular inhibitor of apoptosis protein 2 expression, and functional recovery after traumatic spinal cord injury |
Q37447598 | Tumor necrosis factor-alpha induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kappaB activation |
Q37480241 | USP11 negatively regulates TNFalpha-induced NF-kappaB activation by targeting on IkappaBalpha. |
Q33569888 | Ubiquitin-specific peptidase 21 inhibits tumor necrosis factor alpha-induced nuclear factor kappaB activation via binding to and deubiquitinating receptor-interacting protein 1. |
Q33905168 | Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells |
Q58727377 | Zac1 regulates IL-11 expression in osteoarthritis |
Q34889343 | c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. |
Q34363403 | cis-acting, element-specific transcriptional activity of differentially phosphorylated nuclear factor-kappa B. |
Q41062073 | p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor. |
Search more.